JP2021080303A5 - - Google Patents

Download PDF

Info

Publication number
JP2021080303A5
JP2021080303A5 JP2021036803A JP2021036803A JP2021080303A5 JP 2021080303 A5 JP2021080303 A5 JP 2021080303A5 JP 2021036803 A JP2021036803 A JP 2021036803A JP 2021036803 A JP2021036803 A JP 2021036803A JP 2021080303 A5 JP2021080303 A5 JP 2021080303A5
Authority
JP
Japan
Prior art keywords
composition
biofilm
composition according
genus
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021036803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021080303A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021080303A publication Critical patent/JP2021080303A/ja
Publication of JP2021080303A5 publication Critical patent/JP2021080303A5/ja
Pending legal-status Critical Current

Links

JP2021036803A 2011-03-01 2021-03-09 病原性バイオフィルムと関連した状態を治療するための物質および方法 Pending JP2021080303A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161447735P 2011-03-01 2011-03-01
US61/447,735 2011-03-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018195775A Division JP6908568B2 (ja) 2011-03-01 2018-10-17 病原性バイオフィルムと関連した状態を治療するための物質および方法

Publications (2)

Publication Number Publication Date
JP2021080303A JP2021080303A (ja) 2021-05-27
JP2021080303A5 true JP2021080303A5 (https=) 2021-07-29

Family

ID=45440615

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013556608A Pending JP2014506923A (ja) 2011-03-01 2011-11-04 病原性バイオフィルムと関連した状態を治療するための物質および方法
JP2016148281A Active JP6594269B2 (ja) 2011-03-01 2016-07-28 病原性バイオフィルムと関連した状態を治療するための物質および方法
JP2018195775A Active JP6908568B2 (ja) 2011-03-01 2018-10-17 病原性バイオフィルムと関連した状態を治療するための物質および方法
JP2021036803A Pending JP2021080303A (ja) 2011-03-01 2021-03-09 病原性バイオフィルムと関連した状態を治療するための物質および方法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2013556608A Pending JP2014506923A (ja) 2011-03-01 2011-11-04 病原性バイオフィルムと関連した状態を治療するための物質および方法
JP2016148281A Active JP6594269B2 (ja) 2011-03-01 2016-07-28 病原性バイオフィルムと関連した状態を治療するための物質および方法
JP2018195775A Active JP6908568B2 (ja) 2011-03-01 2018-10-17 病原性バイオフィルムと関連した状態を治療するための物質および方法

Country Status (5)

Country Link
US (11) US9504739B2 (https=)
EP (1) EP2680866A1 (https=)
JP (4) JP2014506923A (https=)
CN (2) CN103687604A (https=)
WO (1) WO2012118535A1 (https=)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
DK3564357T3 (da) 2010-02-01 2022-06-20 Rebiotix Inc Bakterieterapi mod clostridium difficile colitis
CN103687604A (zh) 2011-03-01 2014-03-26 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
EP2836224A4 (en) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
US10557234B2 (en) 2012-05-29 2020-02-11 Neozyme International, Inc. Papermaking additive compositions and methods and uses thereof
US10681914B2 (en) 2012-05-29 2020-06-16 Neozyme International, Inc. Non-toxic plant agent compositions and methods and uses thereof
US10334856B2 (en) 2012-05-29 2019-07-02 Neozyme International, Inc. Non-toxic pest control compositions and methods and uses thereof
DK3659982T3 (da) 2012-05-29 2020-11-09 Neozyme Int Inc Biokatalytisk sammensætning, der er anvendelig ved jordkonditionering
WO2014110580A1 (en) * 2013-01-14 2014-07-17 Ent Associates Of Los Alamos, Llc Honey nasal rinse
EP2762146A1 (en) * 2013-01-31 2014-08-06 Unigroup ApS Composition for Earache
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US11274144B2 (en) 2013-06-13 2022-03-15 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
US20150057574A1 (en) 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
CN103550821A (zh) * 2013-10-31 2014-02-05 天津市中科健新材料技术有限公司 一种吸收性制品用益生元组合物
DE102013112696A1 (de) * 2013-11-18 2015-05-21 Ocean Research & Development Gmbh Verwendung eines Extrakts aus Arthrospira spec. gegen Methicillin-resistente Staphylococcus aureus-Stämme
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
JP6754694B2 (ja) * 2014-03-06 2020-09-16 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル プロバイオティクス製剤および使用のための方法
TW201613625A (en) * 2014-08-29 2016-04-16 Wakamoto Pharma Co Ltd Lactic acid bacteria-containing composition
BR112017004630B1 (pt) 2014-09-30 2023-04-11 Kimberly-Clark Worldwide, Inc Formulação prebiótica sinérgica, lenço prebiótico, e, lenço umedecido prebiótico
MX382504B (es) 2014-09-30 2025-03-13 Kimberly Clark Co Papel tisu crepado prebiotico.
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
US10231941B2 (en) 2015-01-23 2019-03-19 Temple University—Of The Commonwealth System of Higher Educaton Use of short chain fatty acids in cancer prevention
WO2016149687A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
WO2016161074A1 (en) 2015-03-31 2016-10-06 Gojo Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
US9782385B2 (en) * 2015-04-30 2017-10-10 National Health Research Institutes Artificial tears solution combination
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
ES2889902T3 (es) 2015-06-09 2022-01-14 Rebiotix Inc Métodos de fabricación de composiciones para terapia de restauración de la microbiota (TRM)
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
DK3324986T3 (da) 2015-07-20 2022-01-31 Quorum Innovations Llc Materialer og fremgangsmåder til forbedring af immunreaktioner og hud- og/eller slimhindebarrierefunktion
WO2017023863A1 (en) 2015-07-31 2017-02-09 Research Institute At Nationwide Children's Hospital Peptides and antibodies for the removal of biofilms
EP3365027B1 (en) 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Hu specific antibodies and their use in inhibiting biofilm
KR101656875B1 (ko) * 2015-11-13 2016-09-12 건국대학교 산학협력단 단풍나무 추출물, 당단풍나무 추출물 및 박태기나무 추출물을 이용한 그람음성세균 억제용 정족수 감지 억제제
WO2017152027A1 (en) * 2016-03-04 2017-09-08 Rynerson James M Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
ES2935858T3 (es) 2016-05-09 2023-03-13 Adm Denmark As Composición probiótica y usos de la misma
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック/プレバイオティックな有効成分を含む消毒薬組成物
US12337019B2 (en) 2016-12-30 2025-06-24 Northwestern University Vehicles for applying bacteria to skin, scalp, and hair
US11103544B2 (en) * 2016-12-30 2021-08-31 Ann And Robert H. Lurie Children's Hospital Of Chicago Application of honey and bacteria in methods of treating scalp conditions and hair conditions
BR112019018738A2 (pt) * 2017-03-10 2020-04-07 Biohm Health Llc composições e métodos para promoção de uma flora microbiana saudável em um mamífero
RU2657554C1 (ru) * 2017-04-27 2018-06-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) Противовоспалительное средство для профилактики и лечения пародонтита
CN121338053A (zh) * 2017-05-08 2026-01-16 莱雅公司 用于调节角蛋白基质微生物群的装置和方法
WO2019018424A1 (en) * 2017-07-18 2019-01-24 Aobiome Llc MICROORGANISMS OXIDIZING AMMONIA FOR USE AND ADMINISTRATION TO THE VISUAL AND AUDITIVE SYSTEMS
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス, インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
US12077827B2 (en) * 2017-09-29 2024-09-03 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for predicting the risk of developing pulmonary colonization/infection by Pseudomonas aeruginosa
IT201800003804A1 (it) * 2018-03-21 2019-09-21 Neilos S R L Composizione per il trattamento delle patologie respiratorie e orofaringee
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US12365950B2 (en) 2018-06-29 2025-07-22 Osaka University Method of detecting conjunctival disease using ocular surface tissue, and aging biomarker
EP3823651A4 (en) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION
EP3870154A4 (en) 2018-10-22 2022-07-27 Research Institute at Nationwide Children's Hospital COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ANTIBIOTIC-INDUCED PATHOLOGIES USING PROBIOTICS IN BIOFILM STATE
CZ308231B6 (cs) * 2019-02-11 2020-03-11 BiomCare s.r.o. Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace
CA3141892A1 (en) * 2019-05-31 2020-12-03 Thomas Julius Borody Devices, compositions and methods for colonic microbiome engraftment
EP3979830B1 (en) 2019-06-03 2025-11-26 Research Institute at Nationwide Children's Hospital Formulations for the treatment of neurodevelopmental deficiencies induced by necrotizing enterocolitis
US20210102152A1 (en) * 2019-09-03 2021-04-08 University Of Utah Research Foundation Bead biofilm reactor
MX2022006163A (es) 2019-11-26 2022-06-17 Quorum Innovations Llc Nuevas composiciones de barrera protectora y usos de las mismas.
US12010992B2 (en) 2020-04-26 2024-06-18 Neozyme International, Inc. Dry powdered compositions and methods and uses thereof
JP2024521574A (ja) * 2021-06-08 2024-06-03 アダプティブ ファージ セラピューティクス, インコーポレイテッド 改善された抗バイオフィルムアッセイ法
CN113456549B (zh) * 2021-07-20 2023-01-31 广东桂格日化有限公司 一种驱蚊组合物及含有该组合物的花露水
JP2023026359A (ja) * 2021-08-11 2023-02-24 株式会社Raphas Japan カンジダ菌抑制用入浴剤
CN113662971B (zh) * 2021-08-30 2023-02-24 江西省养蜂研究所(江西省蜂业技术推广站) 一种天然蜂粮含片及其生产方法
US20230241126A1 (en) * 2022-01-28 2023-08-03 Ndal Mfg Inc Compositions and methods for disruption of biofilms using fractionated honey
KR102551065B1 (ko) * 2022-05-12 2023-07-03 중앙대학교 산학협력단 김치로부터 유래된 LAB(lactic acid bacteria)을 유효성분으로 포함하는 항-바이오필름 조성물

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5352586A (en) * 1987-05-01 1994-10-04 Biogaia Ab Method of determining the presence of an antibiotic produced by Lactobacillus reuteri
JP2664495B2 (ja) 1989-08-07 1997-10-15 インディアン・ペトロケミカルズ・コーポレーション・リミテッド 被汚染又は使用済プロセススルホランの精製又は再生方法
US5049492A (en) * 1990-03-14 1991-09-17 The United States Of America As Represented By The United States National Aeronautics And Space Administration Biofilm monitoring coupon system and method of use
US6599714B1 (en) 1996-03-13 2003-07-29 University Technologies International Inc. Method of growing and analyzing a biofilm
US6051552A (en) * 1996-05-30 2000-04-18 Urex Biotech, Inc. Lactobacillus therapies
US5935804A (en) * 1997-03-21 1999-08-10 Laine; Roger A. Method for detecting eubacteria in biological samples with catalytically inactive murein binding enzymes
US6455031B1 (en) * 1997-06-18 2002-09-24 David G Davies Methods and compositions for controlling biofilm development
RO113114B1 (ro) 1997-08-05 1998-04-30 Rodica Teodorescu Produs eubiotic natural, pentru intretinerea si tratamentul tegumentelor
EP1159951A1 (en) 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
KR20070035111A (ko) 1998-08-12 2007-03-29 소시에떼 데 프로듀이 네슬레 소시에떼아노님 외인성 유산균의 구강 미소세균총내 도입
WO2000035465A2 (en) * 1998-12-11 2000-06-22 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
US7332200B1 (en) * 1999-05-12 2008-02-19 The General Hospital Corporation Permeabilizing biofilms
AU4905300A (en) * 1999-05-25 2000-12-12 Andrew W. Bruce Oral administration of lactobacillus for the maintenance of health in women
WO2001030806A1 (en) * 1999-10-28 2001-05-03 Smithkline Beecham Corporation Polynucleotides and polypeptides involved in biofilm biology and their uses
JP2002037739A (ja) 2000-07-24 2002-02-06 Mikimoto Pharmaceut Co Ltd 免疫調整剤
WO2002014493A2 (en) * 2000-08-11 2002-02-21 Whitehead Institute For Biomedical Research Control of biofilm development
US20020123077A1 (en) * 2000-09-29 2002-09-05 O'toole George A. Novel compounds capable of modulating biofilms
EP1373553B1 (fr) 2000-10-11 2007-06-13 Université de Liège Procede d'extraction de micro-organismes intacts a partir de boues ou de biofilms
US20050123583A1 (en) * 2000-12-18 2005-06-09 Hsing-Wen Sung Medical use of reuterin
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
WO2002054865A1 (en) * 2001-01-09 2002-07-18 Kurita Water Industries Ltd. Method of selecting antimicrobial agent and method of using the same
EP1228769A1 (de) 2001-02-02 2002-08-07 Jörg-Peter Prof. Schür Symbiontisches Regenerativum
KR100415591B1 (ko) * 2001-03-08 2004-01-16 남양유업 주식회사 위장내 헬리코박터 피로리 감염균의 감소 및 증식억제능이 있는 요구르트 조성물
EP1260227A1 (en) 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
US7189351B2 (en) * 2001-10-25 2007-03-13 Spherix Incorporated D-tagatose as an anti-biofilm agent
EP1483366B1 (en) 2002-02-22 2010-04-14 Blis Technologies Limited Antimicrobial composition
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
CN1642496A (zh) * 2002-03-26 2005-07-20 拜奥辛尼克休斯公司 细菌生物薄膜的酶破坏
US6953574B2 (en) 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US7575744B2 (en) * 2002-11-25 2009-08-18 University Of Georgia Research Foundation, Inc. Composition and method for inhibition of microorganisms
CA2519927A1 (en) 2003-04-02 2004-10-21 Pharmachem Laboratories, Inc. Novel probiotic compositions and methods of using the same
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
KR20060073937A (ko) * 2003-08-18 2006-06-29 더 바이오 밸런스 코포레이션 안정한 액상 촉생제 조성물, 그의 제조 및 응용
WO2005021575A2 (en) * 2003-08-29 2005-03-10 Gregor Reid Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
JP2005083863A (ja) 2003-09-08 2005-03-31 Kobe Steel Ltd 電気的接続検査装置
PL1675481T3 (pl) * 2003-10-24 2009-03-31 Nutricia Nv Kompozycja synbiotyczna dla niemowląt
WO2005109960A2 (en) * 2004-04-30 2005-11-17 Bruno Cynthia K Antagonistic properties of reef fish microflora
GB0410958D0 (en) * 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
US20050287573A1 (en) * 2004-06-18 2005-12-29 North Dakota State University Lined multi-well plates
WO2006108679A2 (en) * 2005-04-15 2006-10-19 Biomac Privatinstitut Für Medizinische Und Zahnmedizinische Forschung, Entwicklung Und Diagnostik Gmbh Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer
WO2006125262A1 (en) * 2005-05-24 2006-11-30 Environmental Biotechnology Crc Pty Limited Methods and compositions for regulating biofilm development
US8038990B2 (en) * 2005-06-01 2011-10-18 The Ohio State University Compositions and methods for the prevention and removal of biofilms on inert and biological surfaces
WO2007004170A2 (en) * 2005-06-30 2007-01-11 Synexa Life Sciences (Proprietary) Limited Production of secondary metabolites using capillary membranes
PT103332A (pt) * 2005-08-12 2007-02-28 Univ Do Minho Sistema de biossorção produzido a partir de biofilmes suportados em zeólito faujasite (fau), processo para a obtenção e sua utilização na remoção de crómio hexavalente (cr(vi))
US20070207095A1 (en) * 2005-12-09 2007-09-06 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
WO2007137369A1 (en) 2006-05-31 2007-12-06 Medihoney Pty Ltd Medicinal compositions containing honey
CA2654656A1 (en) * 2006-06-30 2008-01-03 Biogasol Ipr Aps Production of fermentation products in biofilm reactors using microorganisms immobilised on sterilised granular sludge
US20110008402A1 (en) * 2006-10-13 2011-01-13 Kane Biotech Inc. Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
US20080241281A1 (en) * 2007-03-29 2008-10-02 Texas Tech University System Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development
BRPI0811079A2 (pt) * 2007-05-03 2014-10-21 Tobias Olofsson Bactérias isoladas de mel fresco ou do trato produtor de mel de abelhas melíferas
US8198055B2 (en) * 2007-06-08 2012-06-12 Coskata, Inc. Process for converting syngas to liquid products with microorganisms on two-layer membrane
JP2008308478A (ja) 2007-06-15 2008-12-25 Hiroaki Rikihisa 着色用皮膚外用組成物または日焼け止め用皮膚外用組成物の作成方法及び着色用皮膚外用組成物または日焼け止め用皮膚外用組成物。
US8546071B2 (en) * 2007-07-27 2013-10-01 University Of South Carolina High-throughput in vitro translation (cell-lysate based) assay for detecting quorum sensing signals
CA2694974C (en) 2007-07-30 2016-11-08 University Of Maryland, Baltimore Methods and devices for the detection of biofilm
IL199781A0 (en) * 2009-07-09 2010-05-17 Yohai Zorea Heat resistant probiotic compositions and healthy food comprising them
EP2227213B1 (en) * 2007-11-30 2012-08-29 Toltec Pharmaceuticals, Llc Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
WO2009076226A1 (en) * 2007-12-07 2009-06-18 The Board Of Regents Of The University Of Oklahoma Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
PL2254591T3 (pl) * 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
US20100297295A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Microalgae-Based Beverages
IT1392672B1 (it) * 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
EP2400839B1 (en) * 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
JP2012519659A (ja) * 2009-03-06 2012-08-30 フェデラシオン デ プロダクテュール アセリコール デュ ケベック 共生メープルの生成組成物および方法
PL2411027T3 (pl) * 2009-03-25 2015-04-30 Chr Hansen As Zastosowanie probiotyku do regulowania masy ciała
ES2568730T3 (es) * 2010-10-06 2016-05-04 The Board Of Trustees Of The University Of Arkansas Composiciones anti-biopelícula y métodos de uso
US8906393B2 (en) * 2011-01-26 2014-12-09 Rutgers, The State University Of New Jersey Biofilm inhibiting composition
CN103687604A (zh) * 2011-03-01 2014-03-26 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
US8691538B1 (en) * 2012-09-28 2014-04-08 Algenol Biofuels Switzerland GmbH Biofilm photobioreactor system and method of use

Similar Documents

Publication Publication Date Title
JP2021080303A5 (https=)
JP2014506923A5 (https=)
Depan et al. On the determining role of network structure titania in silicone against bacterial colonization: mechanism and disruption of biofilm
JP2020158526A (ja) 微生物感染の防止及び治療
US20150366920A1 (en) Method for preventing and/or treating infections, colonisations, or illnesses related to staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans and/or malassezia furfur
US20220354985A1 (en) Anti-Microbial Medical Materials and Devices
Constantine et al. The ever-changing role of biofilms in plastic surgery
Yoshida et al. Selective delivery of rifampicin incorporated into poly (dl-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette–Guérin
US20120052052A1 (en) Control of biofilm formation
Jafri et al. In vitro efficacy of clove oil and eugenol against Staphylococcus spp and Streptococcus mutans on hydrophobicity, hemolysin production and biofilms and their synergy with antibiotics
JP2022111186A (ja) 表面から細菌バイオフィルムを低減または除去するためのサーモリシンの使用
Bhuvaneswari et al. Inhibitory concentrations of Lawsonia innermis dry powder for urinary pathogens
Teixeira-Santos et al. Recent advances in antimicrobial surfaces for urinary catheters
Shahid et al. Innovative strategies for the control of biofilm formation in clinical settings
Abdelghafar et al. Combating Staphylococcus aureus biofilm with Antibiofilm agents as an efficient strategy to control bacterial infection
Ewunkem et al. Honeybee wings hold antibiofouling and antimicrobial clues for improved applications in health care and industries
Jang et al. Effect of ion-bombarded silicone tympanostomy tube on ciprofloxacin-resistant Pseudomonas aeruginosa biofilm formation
Puiu et al. Properties of biofilms developed on medical devices
US20200121638A1 (en) Formulation based on vitamin e or an ester thereof for treating bacterial and fungal biofilms
KR102275801B1 (ko) 시스-자스몬을 포함하는 바이오필름 형성 억제용 조성물
Boyar Efficacy of dialkylcarbamoylchloride-coated dressing in management of colonized or infected neonatal and pediatric wounds
Lavryk et al. Ultrastructural changes in biofilm forms of staphylococci cultivated in a mixed culture with lactobacilli
Abd El-Baky Application of scanning electron microscopy for the morphological study of biofilm in medical devices
US20240293482A1 (en) Compositions and methods for treating biofilms, infections and periodontitis
Oh et al. The effect of curcumin against in vitro adhesion of implant device-associated bacteria on nanosized titanium dioxide